The Obesity Action Coalition, the Partnership to Advance Cardiovascular Health and more than 40 healthcare and advocacy organizations are urging the Centers for Medicare & Medicaid Services (CMS) to expand coverage and access to semaglutide for the treatment of obesity. We applaud CMS’s recent decision to cover obesity medications for patients with existing, high-risk cardiovascular
Read Article